N-Acetyl-l-cysteine (NAC) acts as a precursor of the tripeptide glutathione (GSH), one of the principal cell mechanisms for reactive oxygen species (ROS) detoxification. Chronic obstructive pulmonary disease (COPD) is associated with enhanced inflammatory response and oxidative stress and NAC has been used to suppress various pathogenic processes in this disease. Studies show that the effects of NAC are dose-dependent, and it appears that the efficient doses in vitro are usually higher than the achieved in vivo plasma concentrations. However, to date, the inconsistencies between the in vitro NAC antioxidant and anti-inflammatory in vitro effects, by reproducing the in vivo NAC plasma concentrations as well as high NAC concentrations. To do so, A549 were transfected with polyinosinic-polycytidylic acid (Poly (I:C)) and treated with NAC at different treatment periods. Oxidative stress, release of proinflammatory mediators and NFkB activation were analyzed. Results suggest that NAC at low doses in chronic administration has sustained antioxidant and anti-inflammatory effects, while acute treatment with high dose NAC exerts a strong antioxidant and anti-inflammatory response.
28 December 2023 in Journal of Oral Pathology & Medicine
Dental caries prevention can be approached through ecological modulation of the oral biofilm. Among oral probiotics, Streptococcus dentisani stands out for its arginine deiminase (ADI) pathway, producing ammonia with an alkalinizing effect, and for bacteriocins active against cariogenic organisms, suggesting restoration of acid–base homeostasis and displacement of dysbiosis-associated taxa. To systematically review clinical evidence on S. dentisani and other probiotics regarding their effects on pH modulation and oral microbiota shifts. A PRISMA-guided systematic review of PubMed, Scopus, and Web of Science was conducted, including randomized controlled trials (RCTs) and observational studies reporting at least one prespecified outcome (pH or microbiota). Two clinical studies specifically assessed S. dentisani, reporting transient oral colonization, increased salivary alkalinity, and reductions in S. mutans, with one trial documenting a favorable community shift by 16S sequencing. Across the remaining studies, which mainly involved Lactobacillus and Bifidobacterium strains, nine reported reductions in cariogenic markers and five reported increases in pH/buffering capacity; these findings do not pertain to S. dentisani but to other probiotic strains. Caries incidence was evaluated only in lactic probiotic trials with mixed findings; no caries-incidence data were available for S. dentisani. S. dentisani demonstrates consistent mechanistic benefits—pH increase and modulation of the oral microbiota—supporting its candidacy as an oral probiotic. Evidence on caries prevention remains insufficient, underscoring the need for longer, standardized trials incorporating clinical endpoints and microbiological profiling.